With pressure on pharmaceutical companies to reduce time-to-market and impr
ove the success rate of new drug candidates, higher-throughput pharmacokine
tic (HTPK) support has become an integral part of many drug discovery progr
ammes. This report details the amalgamation of robotics, new sample prepara
tion technologies and highly sensitive and selective mass spectrometric det
ection systems to deliver the promise of HTPK. A historical perspective on
automated bioanalysis with the current approaches and future prospects for
the discipline are described.